26 February 2019 Paris
Affordable access to many drugs is made difficult by high prices. At the same time, serious questions are being asked about the degree of innovation and value offered by increasingly costly treatments.
On 26 February 2019, the OECD will hold a one-day workshop in Paris to study the interaction between competition and IP rights in pharmaceutical markets.
Particular focus will be given to:
The workshop offers an opportunity to investigate the impact and role that IP rights play in the pharmaceutical sector while sharing experiences on how to address anticompetitive practices. We will also discuss the challenges of investigating and sanctioning such practices, and to identify potential best practices.
Materials and more information on the speakers will soon become available on this page.
Duncan MATTHEWS Bio
Michael A. CARRIER Bio
The workshop is open to government officials not only from competition authorities but also regulatory agencies in the sector.
Invitations to our contacts have been sent by email. Participants will be able to self-register to this event in MyOECD and indicate if they wish to attend in person or via Webex (distant participation). If you have not received an invitation and would like to attend please contact Sofia Pavlidou.
Two other OECD events are being held back-to-back to this event. For more information:
Any questions related to the scope of the workshop should be sent to Pedro Caro de Sousa.
Questions regarding the logistics of the event can be sent to Sofia Pavlidou.
DOCUMENTS AND LINKS
Generic Pharmaceuticals, 2009